Indeed, in RET melanoma and MC-205 sarcoma mouse models treated with an anti-PD-1 antibody, a 14-day therapy with the ampicillin, colistin, and streptomycin cocktail results in increased tumor volume and reduced overall survival compared to mice not taking antibiotics. The gene discussed is PDCD1; the disease is neoplasm.